CompanyDeals

Nanjing Enrui Kainuo Biotechnology Secures Pre-Series A Funding for Cell Therapy Development

CompanyDrug

Shenzhen Salubris Pharmaceuticals Receives FDA Clearance for SAL0119 Clinical Trial

CompanyDrug

Bio-Thera Solutions Receives NMPA Approval for CTLA-4 and PD-1 Inhibitor Combo Study

CompanyDrug

Shanghai Pharmaceuticals Gets NMPA Green Light for Recombinant Human Adenovirus Type 5 Trial

Policy / Regulatory

China’s NHC Issues Guidelines to Enhance Clinical Department Capacities for Serious Diseases

CompanyDrug

Nanjing Immunophage Biotech’s IPG11406 Approved for SLE Clinical Trial in China

CompanyDeals

Pyrotech (Beijing) Biotechnology Secures $97.37 Million in Series A Financing

Company

Shanghai Henlius Biotech Announces Executive Leadership Changes

CompanyDrug

Zai Lab and argenx Report Positive Preliminary Results from Vyvgart Hytrulo CIDP Study

CompanyDeals

ObsEva SA Regains Full Rights to Nolasiban After Terminating Yuyuan Biological License Deal

CompanyDrug

Janssen’s Rybrevant Meets Primary Endpoint in Phase III NSCLC Study

CompanyDrug

Antengene Corp., Ltd Receives Hong Kong NDA Approval for Xpovio in Relapsed Multiple Myeloma